OHSU Knight Cancer Institute - South Waterfront ( Site 0110) — Portland, Oregon

OHSU Knight Cancer Institute - South Waterfront ( Site 0110) is a clinical research site located in Portland, Oregon, United States 97239.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

OHSU Knight Cancer Institute - South Waterfront ( Site 0110) has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Urinary Bladder Neoplasms, Non-Muscle Invasive Bladder Neoplasms, Carcinoma in Situ.

Sponsors: Merck Sharp & Dohme LLC.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for OHSU Knight Cancer Institute - South Waterfront ( Site 0110)?

OHSU Knight Cancer Institute - South Waterfront ( Site 0110) has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has OHSU Knight Cancer Institute - South Waterfront ( Site 0110) conducted?

OHSU Knight Cancer Institute - South Waterfront ( Site 0110) has 1 clinical trials on record, with 1 currently active. Their work covers Urinary Bladder Neoplasms, Non-Muscle Invasive Bladder Neoplasms, Carcinoma in Situ.

Is OHSU Knight Cancer Institute - South Waterfront ( Site 0110) accredited by Crixeo Health?

OHSU Knight Cancer Institute - South Waterfront ( Site 0110) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about OHSU Knight Cancer Institute - South Waterfront ( Site 0110)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.